Literature DB >> 1309343

Identification and functional characterization of adenylate cyclase-linked receptors for parathyroid hormone-like peptides on immortalized human keratinocytes.

J E Henderson1, R Kremer, J S Rhim, D Goltzman.   

Abstract

We have identified and characterized receptors for the amino-terminal domains of PTH and PTH-like peptide (PLP) on an immortalized human keratinocyte cell line, RHEK-1. Binding of both PLP-(1-34) and PTH-(1-34) to the RHEK-1 cells was consistent with a two-site model; affinities and capacities for each site were similar for the two peptides. Both peptides also stimulated adenylate cyclase activity with an equal ED50 in this cell line. Pertussis toxin pretreatment enhanced this peptide-mediated enzyme activity, suggesting linkage of the receptor to an inhibitory guanyl nucleotide-binding protein (Gi). Adenylate cyclase activity was diminished by both homologous [PLP-(1-34)] and heterologous [epidermal growth factor (EGF)] effectors. Malignant conversion of the immortalized cells with an activated H-ras oncogene to produce the RHEK-ras cell line was associated with a reduction in binding at both PLP/PTH and EGF receptors as well as a postreceptor defect in PLP/PTH-stimulated adenylate cyclase activity. The defect in enzyme activity appeared to be due in part to a decrease in the activity of the stimulatory guanyl nucleotide-binding protein (Gs), but not to an increase in Gi activity. Activation of the keratinocyte amino-terminal PLP/PTH receptor resulted in a small increase in [3H]thymidine incorporation, which was associated with an increase in cell numbers. This mitogenic effect was enhanced in the presence of EGF and was markedly reduced when cells were cultured in a high extracellular calcium environment. These studies demonstrate that the amino-terminal region of PLP and PTH activates adenylate cyclase-linked receptors, which are associated with mitogenesis, in RHEK-1 cells and suggest that this cell line represents a suitable model in which to examine the actions of PLP in keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1309343     DOI: 10.1210/endo.130.1.1309343

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.

Authors:  John Foley; Nicole Nickerson; David J Riese; Peter C Hollenhorst; Gwendolen Lorch; Anne M Foley
Journal:  Odontology       Date:  2012-06-10       Impact factor: 2.634

2.  Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development.

Authors:  J J Wysolmerski; A E Broadus; J Zhou; E Fuchs; L M Milstone; W M Philbrick
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

3.  Expression of parathyroidlike protein in normal, proliferative, and neoplastic human breast tissues.

Authors:  H Liapis; E C Crouch; L E Grosso; S Kitazawa; M R Wick
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 4.  Phosphate: known and potential roles during development and regeneration of teeth and supporting structures.

Authors:  Brian L Foster; Kevin A Tompkins; R Bruce Rutherford; Hai Zhang; Emily Y Chu; Hanson Fong; Martha J Somerman
Journal:  Birth Defects Res C Embryo Today       Date:  2008-12

5.  The Parathyroid Hormone Second Receptor PTH2R and its Ligand Tuberoinfundibular Peptide of 39 Residues TIP39 Regulate Intracellular Calcium and Influence Keratinocyte Differentiation.

Authors:  Emi Sato; Jun Muto; Ling-Juan Zhang; Christopher A Adase; James A Sanford; Toshiya Takahashi; Teruaki Nakatsuji; Ted B Usdin; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2016-03-19       Impact factor: 8.551

6.  Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death.

Authors:  J E Henderson; N Amizuka; H Warshawsky; D Biasotto; B M Lanske; D Goltzman; A C Karaplis
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.